DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

Published June 25, 2026 · Category: Markets

Overview

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="left">SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two...

Source

Originally published at markets.businessinsider.com.

Related Articles

• MEXC Lists Five ONDO Tokenized Stocks Trading Pairs Across AI, Semiconductors, and Energy
• Beam Global Relocates Manufacturing Operations to Yuma, AZ
• Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development